Edwards Lifesciences Q3: Strong Growth & Optimistic Outlook

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded11 Nov 2025

Publisherfeeds.acast.com ↗

Handlerec:2197530

Show notes

Edwards Lifesciences, a pioneer in medical technology since 1958, reported robust third-quarter results, with a 15% revenue surge to $1.55 billion. Their transcatheter mitral and tricuspid therapies drove this growth, increasing by over 50%. Despite a slight underperformance compared to the S&P 500, their stock has risen 27% over the past year and 13.6% YTD. Edwards Lifesciences raised their full-year 2025 sales and earnings forecast, reflecting optimism in their business momentum and future prospects. Analysts maintain a Moderate Buy consensus, with some predicting an 11% potential upside from current market prices.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.